We want to hear about your experiences with our wound and scar products. Send us your case studies and get a free 100g of either product.
We want to hear about your experiences with our wound and scar products. Send us your case studies and get a free 100g of either product.
We want to hear about your experiences with our wound and scar products. Send us your case studies and get a free 100g of either product.

Oral Publications

Oral Bases

Beyond Use Date (BUD) studies are conducted in order to establish the conserved potency of an active after an adequate period of time and to guarantee the quality, purity and stability of compounded preparations. Accurate results ensure that a medication has maintained its compounded dosage form.

  • Vancomycin 50mg/mL Adobe
    Smith, A. D. Rempel, G. Szeitz, A. Klassen, T. L. Ensom, M. H. H. (2017).
    Vancomycin 50 mg/mL Suspension in Oral Syrup: Stability in Plastic Bottles and Syringes at 2 Temperatures.
    CJHP Vol 70 No.3
  • Gabapentin 100mg/mL Adobe
    Friciu, M. Roullin, V. G. Leclair, G. (2017).
    Stability of gabapentin in extemporaneously compounded oral suspensions.
    PLOS ONE 12(4) e0175208. doi: 10.1371/journal.pone.0175208
  • Hydroxychloroquine sulfate 25mg/mL Adobe
    McHenry, A. R. Wempe, M. F. Rice, P. J. (2017).
    Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes.
    IJPC. Vol. 21, No 3.
  • Tacrolimus 0.5mg/mL Adobe
    Friciu, M. Zaraa, S. Leclair, G. (2017).
    Stability of Extemporaneously Compounded Tacrolimus in Glass Bottles and Plastic Syringes.
    CJHP. Vol 70.No 1
  • Enalapril maleate 1mg/mL Adobe
    Friciu, M. Zaraa, S. Leclair, G. (2016).
    Stability of Extemporaneously Prepared Enalapril Maleate in Glass Bottles and Plastic Syringes.
    CJHP. Vol 69.No 6
  • Diazoxide 10mg/mL Adobe
    Friciu, M. Zaraa, S. Roullin, V. G. Leclair, G. (2016).
    Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions.
    PLOS One 11(10) e0164577. doi:10.1371/journal.pone.0164577
  • Amlodipine 1mg/mL Adobe
    Friciu, M. Zaraa, S. Leclair, G. (2016).
    Stability of Extemporaneously Compounded Amlodipine Besylate Oral Suspensions.
    CJHP. Vol 69.No 4.
  • Piroxicam Suspension 10mg/mL - Veterinary Use Adobe
    Rase, T. M. Purohit, V. (2016).
    Stability of Extemporaneously Compounded Piroxicam 10mg/mL suspension with acetate buffer.
    Santa Clara County Veterinary Medical Association (SCCVMA) Annual Meeting 2016: Poster Abstract.
  • Trimethoprim Suspension 10mg/mL Adobe
    Ensom, H. H. Mary, Decarie, D. (2016).
    Stability of Extemporaneously Compounded Trimethoprim in Glass and Plastic Bottles and Plastic Syringes.
    CJHP. Vol 69, No 2.
  • Melatonin Suspension 2mg/mL Adobe
    Friciu, M. Savji, T. Zaraa, S. Leclair, G. (2016).
    Evaluation of stability of melatonin in extemporaneously compounded oral suspensions.
    JPPR. Vol 46, Issue 1.
  • Dexamethasone (using tablets) Suspension 1mg/mL Adobe
    Ensom, H. H. Mary, Decarie, D. (2016).
    Dexamethasone 1 mg/mL Suspension Prepared from Crushed Tablets: Stability in Glass and Plastic Bottles and Plastic Syringes
    CJHP. Vol 69, No 1.
  • Levetiracetam Suspension 50mg/mL Adobe
    Ensom, H. H. Mary, Decarie, D. (2015).
    Stability of Extemporaneously Compounded Levetiracetam in Glass and Plastic Bottles and Plastic Syringes.
    CJHP. Vol 68, No 4.
  • Naproxen Suspension 25mg/mL Adobe
    Ensom, H. H. M., Decarie, D. Lingertat-Walsh, K. (2015).
    Stability of Extemporaneously Compounded Naproxen 25 mg/mL Suspension in Glass and Plastic Bottles and Plastic Syringes.
    CJHP. Vol 68, No 6.
  • Prednisone Suspension 5mg/mL Adobe
    Friciu, M. Plourde, K. Leclair, G. Danopoulos, P. Savji, T. (2015).
    Stability of Prednisone in Oral Mix Suspending Vehicle.
    IJPC. Vol 19, No4
  • Clobazam Suspension 1mg/mL Adobe
    Walsh Lingertat, K., Walsh, A., Ziegler, B., Walker, S. E., Law, S., Sales, P. (2014).
    Stability of extemporaneously compounded Clobazam 1mg/mL suspension.
    CSHP Professional Practice Conference.
  • Clonidine Suspension 0.010mg/mL Adobe
    Ensom, H. H. Mary, Decarie, D. (2014).
    Stability of Extemporaneously Compounded Clonidine in Glass and Plastic Bottles and Plastic Syringes.
    CJHP. Vol 67, No 4.
  • Dexamethasone Suspension 1mg/mL Adobe
    Ensom, H. H. Mary, Decarie, D. (2014).
    Stability of Extemporaneously Compounded Dexamethasone in Glass and Plastic Bottles and Plastic Syringes.
    CJHP. Vol 67, No 4.
  • Pyridoxine Suspension 25mg/mL Adobe
    Ensom, H. H. Mary, Decarie, D. (2014).
    Stability of Extemporaneously Compounded Pyridoxine in Glass and Plastic Bottles and Plastic Syringes.
    CJHP. Vol 67, No 5.
  • Spironolactone Suspension 5mg/mL Adobe
    BasuSarkar, A. Kandimalla, A. Dudley, R. (2013).
    Chemical Stability of Compounded Spironolactone Suspension in Proprietary Oral Mix Over a 90-day Period at Two Controlled Temperatures in Different Storage Containers.
    Int. J. Pharm. Sci. Rev. Res. Vol 23(1), No 14
  • Premixed Excipient Blends Adobe
    Capsules have played a crucial role in drug delivery for pharmaceutical applications, although they tend to be difficult to prepare. To minimize the challenge of excipient selection and blend preparation, MEDISCA tests solubility and permeability, enhancing high level of efficiency of compounded capsules and ensuring dissolution of actives ingredients.
    Pinheiro, V. Danopoulos, P. Demirdjian, L. Nogueira, R. Dubois, F. (2013).
    In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutical Classification System (BCS) of the drugs.
    IJPC. Vol. 17. No 5.



GO BACK



Copyright® 1986-2017 Medisca Inc.
All rights reserved

MEDISCA is ISO 9001:2008 certified MEDISCA is a proud VAWD-accredited facility